Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

The Expanding Osteoporosis Market: Potential of Current and New Drugs

Published by: Decision Resources

Published: Sep. 29, 2005 - 16 Pages

The price of this report has been reduced due to its age. The original price was $1,900 for PDF E-mail From Publisher.

Table of Contents


Introduction

The Disease

Causes of Osteoporosis

Disease Prevalence

Current Treatments

Bisphosphonates

Selective Estrogen Receptor Modulators

Parathyroid Hormone Agonists

Calcitonin

Vitamin D and Vitamin D Analogues

Hormone Replacement Therapy

Other Treatments

Current Market

New Treatments

Emerging Agents in Currently Marketed Drug Classes

New Drug Classes

Market Outlook

Generic Drug Threats

Osteoporosis Market Through 2009




Table 1. Sales of Select Branded Drugs for the Treatment of Osteoporosis, 2004

Table 2. Agents in Currently Marketed Drug Classes in Development for Osteoporosis, 2004

Table 3. New Approaches to Drug Treatment of Osteoporosis, 2005

Table 4. Estimated Sales of Select Drug Classes for the Treatment of Osteoporosis, 2009 (millions of U.S. dollars)




Figure 1. Osteoporisis Drug Class Sales in Europe and the U.S., 2004

Figure 2. Osteoporisis Drug Class Sales in Japan, 2004

Abstract

The demand for drugs to treat osteoporosis will grow substantially during the next ten years. This growth will be driven by increasing market penetration facilitated by better diagnosis of the disease, the large aging population, and increasing treatment of male osteoporosis. A further stimulus to growth will be the availability of new agents. In this report, we provide an overview of osteoporosis, including its etiology and its worldwide prevalence. We discuss marketed treatments for the disease and present an outline of the current market and major players. The report also identifies the most promising drugs in development for the treatment of osteoporosis, including agents in currently marketed drug classes and those representing novel approaches to osteoporosis treatment. Finally, we forecast sales of osteoporosis agents through 2009, identifying the drugs most likely to have a significant impact and discussing potential threats from generic agents.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009